Back to Journals » OncoTargets and Therapy » Volume 11

Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung

Total article views   HTML views PDF downloads Totals
9,103 Dovepress* 8,443+ 851 9,294
PubMed Central* 660 229 889
Totals 9,103 1,080 10,183
*Since 30 November 2018
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 1 3

View citations on PubMed Central and Google Scholar